Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023.
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023.
A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of Science 37’s website at: https://investors.science37.com and will be archived for 90 days.
AboutScience37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite™ Science 37 reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own home, at their local community provider, or at a traditional site when needed. The Science 37 Metasite is powered by a proprietary technology platform, in addition to in-house investigators, mobile nurses, and remote coordinators that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.
Contacts:
MEDIAINQUIRIES:
Grazia Mohren
Science 37
Email: pr@science37.com
INVESTORRELATIONS:
Steve Halper
LifeSci Advisors
Email: shalper@lifesciadvisors.com
